MARATTO

article · Scientific Reports

Tuning the structural, optical properties and antibacterial activity of poly(vinyl chloride)/poly(methyl methacrylate)/silver oxide nanocomposites for potential optoelectronic and medical applications

Abstract

The fabrication of ternary nanocomposites attracts great interest in scientific research worldwide. PVC/PMMA/AgO nanocomposites are prepared by the casting method with various proportions of AgONPs. Analysis of XRD and FTIR spectra exhibited that the structural parameters of PVC/PMMA blend have been affected with increasing nanofiller content. UV–Vis spectra analysis showed that the direct/indirect energy gap are decreased from (5.21/4.92) to (4.86/3.90) eV and the dispersion and oscillation (Ed/Eo) energies are increased from (1.186/4.437) to (73.323/13.638) eV with increasing the content of AgONPs. Linear/nonlinear optical parameters of PVC/PMMA/AgO nanocomposites are enhanced upon increasing AgONPs content. This study also showed that the antibacterial activity of PVC/PMMA/AgO nanocomposites against Gram-positive bacteria (S. aureus, B. subtilis) and Gram-negative bacteria (E. coli) is enhanced. Generally, PVC/PMMA/AgO nanocomposites show promising potential in the field of flexible optoelectronic devices due to the structure-dependent adjustable optical energy gap and in the medical field for their pronounced antibacterial activity.

Research topics

  • Polymer Nanocomposite Synthesis and Irradiation
  • Polymer Science and PVC
  • Polymer Nanocomposites and Properties

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1038/s41598-025-23164-y

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.